600976 健民集团
已收盘 01-23 15:00:00
资讯
新帖
简况
每周股票复盘：健民集团（600976）拟捐150万支持儿童呼吸研究
证券之星 · 02:57
每周股票复盘：健民集团（600976）拟捐150万支持儿童呼吸研究
健民集团（600976）披露向中国健康促进基金会捐赠150万元用于儿童呼吸与药学课题研究，1月23日股价上涨0.95%
证券之星 · 01-23 22:52
健民集团（600976）披露向中国健康促进基金会捐赠150万元用于儿童呼吸与药学课题研究，1月23日股价上涨0.95%
健民集团(600976.SH)：氨溴特罗口服溶液获批上市
智通财经 · 2025-12-10
健民集团(600976.SH)：氨溴特罗口服溶液获批上市
健民集团：东北证券、海通证券等多家机构于11月27日调研我司
证券之星 · 2025-12-03
健民集团：东北证券、海通证券等多家机构于11月27日调研我司
健民集团（600976）披露为子公司银行授信额度提供担保实施公告，11月26日股价上涨0.24%
证券之星 · 2025-11-26
健民集团（600976）披露为子公司银行授信额度提供担保实施公告，11月26日股价上涨0.24%
健民集团：西安金本科技实业有限公司、上海牛福投资管理等多家机构于10月23日调研我司
证券之星 · 2025-11-04
健民集团：西安金本科技实业有限公司、上海牛福投资管理等多家机构于10月23日调研我司
健民集团（600976）2025年三季报简析：净利润同比下降11.16%，三费占比上升明显
证券之星 · 2025-10-23
健民集团（600976）2025年三季报简析：净利润同比下降11.16%，三费占比上升明显
健民集团(600976)9月30日股东户数1.43万户，较上期减少16.17%
证券之星 · 2025-10-21
健民集团(600976)9月30日股东户数1.43万户，较上期减少16.17%
健民集团(600976.SH)发布前三季度业绩，归母净利润2.86亿元，同比下降11.16%
智通财经 · 2025-10-21
健民集团(600976.SH)发布前三季度业绩，归母净利润2.86亿元，同比下降11.16%
每周股票复盘：健民集团（600976）将召开2025年三季报说明会
证券之星 · 2025-10-19
每周股票复盘：健民集团（600976）将召开2025年三季报说明会
健民集团（600976）披露召开2025年第三季度业绩说明会公告，10月14日股价下跌0.1%
证券之星 · 2025-10-14
健民集团（600976）披露召开2025年第三季度业绩说明会公告，10月14日股价下跌0.1%
每周股票复盘：健民集团（600976）为子公司提供5000万元担保
证券之星 · 2025-10-12
每周股票复盘：健民集团（600976）为子公司提供5000万元担保
健民集团披露总额5000万元的对外担保，被担保方为武汉健民药业集团维生药品有限责任公司
证券之星 · 2025-10-11
健民集团披露总额5000万元的对外担保，被担保方为武汉健民药业集团维生药品有限责任公司
健民集团（600976）披露对子公司银行授信额度提供担保的实施公告，10月10日股价上涨0.2%
证券之星 · 2025-10-10
健民集团（600976）披露对子公司银行授信额度提供担保的实施公告，10月10日股价上涨0.2%
股市必读：健民集团（600976）9月30日披露最新机构调研信息
证券之星 · 2025-10-09
股市必读：健民集团（600976）9月30日披露最新机构调研信息
每周股票复盘：健民集团（600976）上半年净利下降但扣非后增60%
证券之星 · 2025-09-07
每周股票复盘：健民集团（600976）上半年净利下降但扣非后增60%
股市必读：健民集团（600976）9月1日披露最新机构调研信息
证券之星 · 2025-09-02
股市必读：健民集团（600976）9月1日披露最新机构调研信息
健民集团：富国基金、国海证券等多家机构于8月21日调研我司
证券之星 · 2025-09-01
健民集团：富国基金、国海证券等多家机构于8月21日调研我司
健民集团：呋塞米口服溶液获批上市
金融界 · 2025-09-01
健民集团：呋塞米口服溶液获批上市
每周股票复盘：健民集团（600976）股东户数增加3855户，主营收入下降10.2%
证券之星 · 2025-08-24
每周股票复盘：健民集团（600976）股东户数增加3855户，主营收入下降10.2%
加载更多
公司概况
公司名称：
健民药业集团股份有限公司
所属行业：
零售业
上市日期：
2004-04-19
主营业务：
健民药业集团股份有限公司的主营业务是药品的研发、制造、批发与零售业务。公司的主要产品是龙牡壮骨颗粒、便通胶囊、健脾生血颗粒、健脾生血片、小金胶囊、小儿宝泰康颗粒、便通胶囊、中成药、化学药品、生物制剂、保健品、中医诊疗。公司是国家高新技术企业，技术中心通过国家企业技术中心认定。
发行价格：
11.60
{"stockData":{"symbol":"600976","market":"SH","secType":"STK","nameCN":"健民集团","latestPrice":35.21,"timestamp":1769151602000,"preClose":34.88,"halted":0,"volume":1339100,"delay":0,"changeRate":0.0095,"floatShares":153000000,"shares":153000000,"eps":2.1272,"marketStatus":"已收盘","change":0.33,"latestTime":"01-23 15:00:00","open":35,"high":35.21,"low":34.89,"amount":47047400,"amplitude":0.0092,"askPrice":35.21,"askSize":113,"bidPrice":35.2,"bidSize":1,"shortable":0,"etf":0,"ttmEps":2.1272,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769391000000},"marketStatusCode":5,"adr":0,"adjPreClose":34.88,"symbolType":"stock","openAndCloseTimeList":[[1769131800000,1769139000000],[1769144400000,1769151600000]],"highLimit":38.37,"lowLimit":31.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":153398600,"isCdr":false,"pbRate":2.09,"roa":"--","peRate":16.552275,"roe":"11.42%","epsLYR":2.38,"committee":-0.314917,"marketValue":5401000000,"turnoverRate":0.0087,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-01-26。","floatMarketCap":5398000000},"requestUrl":"/m/hq/s/600976","defaultTab":"news","newsList":[{"id":"2606232102","title":"每周股票复盘：健民集团（600976）拟捐150万支持儿童呼吸研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2606232102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606232102?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:57","pubTimestamp":1769281028,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，健民集团报收于35.21元，较上周的34.8元上涨1.18%。本周，健民集团1月23日盘中最高价报35.21元。本周关注点公司公告汇总：健民集团拟捐赠150万元用于儿童呼吸与药学课题研究。健民集团于2026年1月23日召开第十一届董事会第六次会议，审议通过向中国健康促进基金会捐赠150万元的议案。捐赠资金来源于公司自有资金，用途为支持儿童呼吸与药学相关课题研究项目，目前捐赠协议尚未签署。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0209","BK0250","600976"],"gpt_icon":0},{"id":"2605840622","title":"健民集团（600976）披露向中国健康促进基金会捐赠150万元用于儿童呼吸与药学课题研究，1月23日股价上涨0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605840622","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605840622?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:52","pubTimestamp":1769179938,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，健民集团报收于35.21元，较前一交易日上涨0.95%，最新总市值为54.01亿元。公告显示，公司于2026年1月23日召开第十一次董事会第六次会议，审议通过向中国健康促进基金会捐赠150万元的议案。该款项将用于支持儿童呼吸与药学相关课题研究项目，资金来源为公司自有资金。捐赠协议尚未签署。中国健康促进基金会为民政部注册的公益慈善组织，业务范围包括健康管理、学术交流等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600976","BK0209","BK0250"],"gpt_icon":0},{"id":"2590588380","title":"健民集团(600976.SH)：氨溴特罗口服溶液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2590588380","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590588380?lang=zh_cn&edition=full","pubTime":"2025-12-10 17:23","pubTimestamp":1765358619,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健民集团(600976.SH)发布公告，近日，公司从国家药品监督管理局网站获悉，公司研发的氨溴特罗口服溶液获批上市。氨溴特罗口服溶液是由盐酸氨溴索和盐酸克仑特罗组成的复方制剂。其中盐酸氨溴索为粘液溶解剂，能降低痰液粘度，使痰液易于咳出;盐酸克仑特罗为选择性β受体激动剂，有松弛支气管平滑肌、促进痰液排出的作用。两种成分起到很好的止咳排痰协同作用。公司研发的该品种与原研参比制剂有相同的活性成分、辅料、剂型、规格、适应症、给药途径和用法用量，该品种临床应用成熟，市场容量较大。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379914.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"健民集团(600976.SH)：氨溴特罗口服溶液获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0209","600976","BK0188","BK0250"],"gpt_icon":0},{"id":"2588096874","title":"健民集团：东北证券、海通证券等多家机构于11月27日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588096874?lang=zh_cn&edition=full","pubTime":"2025-12-03 10:32","pubTimestamp":1764729123,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年12月2日健民集团发布公告称东北证券、海通证券、交银施罗德、银河基金、西部利得基金、嘉实基金于2025年11月27日调研我司。目前该产品发展状况良好,呈持续增长状态。答：七蕊胃舒胶囊和小儿紫贝宣肺糖浆为公司先后获批上市的中药1.1类创新药产品。健民集团主营业务：药品的研发、制造、批发与零售业务。融资融券数据显示该股近3个月融资净流出2230.97万，融资余额减少；融券净流出15.82万，融券余额减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300009161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","600976","BK0028","BK0070","BK0012","BK1147","BK0250","BK0276","BK0188","600837","BK0209","BK1564","06837","000686"],"gpt_icon":0},{"id":"2586026809","title":"健民集团（600976）披露为子公司银行授信额度提供担保实施公告，11月26日股价上涨0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586026809","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586026809?lang=zh_cn&edition=full","pubTime":"2025-11-26 22:27","pubTimestamp":1764167239,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，健民集团报收于37.8元，较前一交易日上涨0.24%，最新总市值为57.98亿元。公司近日发布公告称，健民药业集团股份有限公司为全资子公司武汉健民药业集团维生药品有限责任公司向交通银行股份有限公司汉阳支行申请的2,500万元授信敞口额度提供连带责任保证担保，担保期限一年，担保范围包括主债权本金及利息、复利、罚息、违约金、损害赔偿金和实现债权的费用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600039018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","600976","BK0209","161121","BK0188"],"gpt_icon":0},{"id":"2580586271","title":"健民集团：西安金本科技实业有限公司、上海牛福投资管理等多家机构于10月23日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2580586271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580586271?lang=zh_cn&edition=full","pubTime":"2025-11-04 10:32","pubTimestamp":1762223565,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月3日健民集团发布公告称西安金本科技实业有限公司、上海牛福投资管理、太平洋证券、深圳蓝马资本、深圳市德远投资、深圳国安保证担保、晋江泉智私募基金、深圳市北斗星投资、珠海市横琴天勤资产管理于2025年10月23日调研我司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400011075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600976","BK0250","BK0188","BK0209"],"gpt_icon":0},{"id":"2577317076","title":"健民集团（600976）2025年三季报简析：净利润同比下降11.16%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2577317076","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577317076?lang=zh_cn&edition=full","pubTime":"2025-10-23 06:02","pubTimestamp":1761170558,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期健民集团发布2025年三季报。截至本报告期末，公司营业总收入25.52亿元，同比下降11.43%，归母净利润2.86亿元，同比下降11.16%。本报告期健民集团三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达34.42%。去年的净利率为10.49%，算上全部成本后，公司产品或服务的附加值一般。持有健民集团最多的基金为银河医药混合A，目前规模为4.91亿元，最新净值0.5919，较上一交易日下跌1.33%，近一年上涨13.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300004036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600976"],"gpt_icon":0},{"id":"2577284003","title":"健民集团(600976)9月30日股东户数1.43万户，较上期减少16.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577284003","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577284003?lang=zh_cn&edition=full","pubTime":"2025-10-21 17:09","pubTimestamp":1761037794,"startTime":"0","endTime":"0","summary":"证券之星消息，近日健民集团披露，截至2025年9月30日公司股东户数为1.43万户，较6月30日减少2751.0户，减幅为16.17%。在中药行业个股中，健民集团股东户数低于行业平均水平，截至9月30日，中药行业平均股东户数为5.3万户。从股价来看，2025年6月30日至2025年9月30日，健民集团区间涨幅为2.93%，在此期间股东户数减少2751.0户，减幅为16.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100025864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","600976","BK0209","BK0188"],"gpt_icon":0},{"id":"2577840695","title":"健民集团(600976.SH)发布前三季度业绩，归母净利润2.86亿元，同比下降11.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577840695","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577840695?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:59","pubTimestamp":1761037170,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健民集团(600976.SH)披露2025年第三季度报告，公司前三季度实现营收25.52亿元，同比下降11.43%;归属于上市公司股东的净利润2.86亿元，同比下降11.16%;扣非净利润2.56亿元，同比下降5.58%;基本每股收益1.88元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600976"],"gpt_icon":0},{"id":"2576044428","title":"每周股票复盘：健民集团（600976）将召开2025年三季报说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2576044428","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576044428?lang=zh_cn&edition=full","pubTime":"2025-10-19 05:28","pubTimestamp":1760822895,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，健民集团报收于40.02元，较上周的40.29元下跌0.67%。本周，健民集团10月16日盘中最高价报40.73元。健民集团当前最新总市值61.39亿元，在中药板块市值排名39/67，在两市A股市值排名2741/5158。本周关注点公司公告汇总：健民集团将于2025年10月22日召开第三季度业绩说明会。健民药业集团股份有限公司将于2025年10月22日16:00-17:00通过上海证券交易所上证路演中心举行2025年第三季度业绩说明会，以网络文字互动方式召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","BK0188","600976"],"gpt_icon":0},{"id":"2575214181","title":"健民集团（600976）披露召开2025年第三季度业绩说明会公告，10月14日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575214181","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575214181?lang=zh_cn&edition=full","pubTime":"2025-10-14 22:48","pubTimestamp":1760453299,"startTime":"0","endTime":"0","summary":"截至2025年10月14日收盘，健民集团报收于39.73元，较前一交易日下跌0.1%，最新总市值为60.95亿元。近日，健民集团发布《关于召开2025年第三季度业绩说明会的公告》。公告称，公司将于2025年10月22日16:00-17:00通过上海证券交易所上证路演中心以网络文字互动方式举行2025年第三季度业绩说明会。届时，公司将发布《2025年第三季度报告》，并就经营成果、财务状况及投资者关注的问题进行交流。说明会后，会议情况可通过上证路演中心查看。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400065705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0209","BK0188","600976"],"gpt_icon":0},{"id":"2574450054","title":"每周股票复盘：健民集团（600976）为子公司提供5000万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2574450054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574450054?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:55","pubTimestamp":1760208914,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，健民集团报收于40.29元，较上周的40.36元下跌0.17%。本周，健民集团10月10日盘中最高价报40.54元。本周关注点公司公告汇总：健民集团为子公司维生药品向中信银行申请5,000万元综合授信提供连带责任保证。公司公告汇总健民集团为支持全资子公司武汉健民药业集团维生药品有限责任公司发展，拟为其向中信银行股份有限公司武汉分行申请的5,000万元综合授信敞口额度提供连带责任保证，担保期限一年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0250","BK0188","600976"],"gpt_icon":0},{"id":"2574513274","title":"健民集团披露总额5000万元的对外担保，被担保方为武汉健民药业集团维生药品有限责任公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2574513274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574513274?lang=zh_cn&edition=full","pubTime":"2025-10-11 20:12","pubTimestamp":1760184720,"startTime":"0","endTime":"0","summary":"健民集团10月10日披露总额5000万元的对外担保，被担保方为武汉健民药业集团维生药品有限责任公司。本次担保的担保方式为连带责任担保。 被担保方武汉健民药业集团维生药品有限责任公司注册资本5000万人民币，公司法人为李德烽，所属行业为批发业，公司成立于1999年12月30日。数据来源：天眼查APP \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-11/doc-inftprkf0168367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0209","600976","BK0188","BK0250"],"gpt_icon":0},{"id":"2574177514","title":"健民集团（600976）披露对子公司银行授信额度提供担保的实施公告，10月10日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574177514","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574177514?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:38","pubTimestamp":1760107104,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，健民集团报收于40.29元，较前一交易日上涨0.2%，最新总市值为61.8亿元。近日，健民集团发布关于对子公司银行授信额度提供担保的实施公告。公告称，公司为支持全资子公司武汉健民药业集团维生药品有限责任公司发展，拟为其向中信银行股份有限公司武汉分行申请的5,000万元综合授信敞口额度提供连带责任保证，担保期限一年。截至2025年9月30日，公司对控股子公司担保余额为12,700万元，占2024年经审计净资产的14.62%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0188","600976","BK0209","161121"],"gpt_icon":0},{"id":"2574979699","title":"股市必读：健民集团（600976）9月30日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2574979699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574979699?lang=zh_cn&edition=full","pubTime":"2025-10-09 02:25","pubTimestamp":1759947914,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘，健民集团报收于40.36元，下跌0.79%，换手率1.14%，成交量1.74万手，成交额7028.43万元。当日关注点来自交易信息汇总：9月30日主力资金净流出1332.58万元，占总成交额18.96%。2025年上半年医药工业收入同比增长23.07%。OTC产品中龙牡壮骨颗粒实现增长，便通胶囊快速增长，健脾生血颗粒实现区域性销量突破。参股子公司武汉健民大鹏药业有限公司仍为国内唯一拥有体外培育牛黄原料药批准文号的企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900000697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0188","600976","BK0209"],"gpt_icon":0},{"id":"2565097510","title":"每周股票复盘：健民集团（600976）上半年净利下降但扣非后增60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565097510","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565097510?lang=zh_cn&edition=full","pubTime":"2025-09-07 03:09","pubTimestamp":1757185752,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，健民集团报收于41.6元，较上周的42.43元下跌1.96%。本周，健民集团9月4日盘中最高价报43.33元。本周关注点业绩披露要点：上半年归母净利润同比下降7.83%，扣除投资收益及非经常性损益影响后同比增长约60%。呋塞米整体销售额2022年为6.9亿元，2023年7.35亿元，2024年6.03亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","600976","BK0209","BK0188"],"gpt_icon":0},{"id":"2564759841","title":"股市必读：健民集团（600976）9月1日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2564759841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564759841?lang=zh_cn&edition=full","pubTime":"2025-09-02 02:40","pubTimestamp":1756752025,"startTime":"0","endTime":"0","summary":"截至2025年9月1日收盘，健民集团报收于42.63元，上涨0.47%，换手率2.16%，成交量3.31万手，成交额1.4亿元。来自公司公告汇总：公司研发的呋塞米口服溶液获批上市，适用于儿童及成人水肿和高血压治疗，累计投入研发费用约805.23万元。目前国内另有3家企业持有该品种批准文号，呋塞米整体销售额2022年为6.9亿元，2023年7.35亿元，2024年6.03亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200001341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0250","BK0209","600976"],"gpt_icon":0},{"id":"2564081265","title":"健民集团：富国基金、国海证券等多家机构于8月21日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2564081265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564081265?lang=zh_cn&edition=full","pubTime":"2025-09-01 20:13","pubTimestamp":1756728816,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年9月1日健民集团发布公告称富国基金、国海证券于2025年8月21日调研我司。健民集团2025年中报显示，公司主营收入18.05亿元，同比下降10.2%；归母净利润2.21亿元，同比下降7.83%；扣非净利润1.95亿元，同比上升0.61%；其中2025年第二季度，公司单季度主营收入9.13亿元，同比下降12.21%；单季度归母净利润1.1亿元，同比下降21.01%；单季度扣非净利润9241.52万元，同比下降10.99%；负债率41.44%，投资收益6726.55万元，财务费用546.26万元，毛利率59.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090100031432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600976","000750","BK0250","BK0276","BK0209","BK0183","BK0174","BK0028","BK0188"],"gpt_icon":0},{"id":"2564816561","title":"健民集团：呋塞米口服溶液获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2564816561","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564816561?lang=zh_cn&edition=full","pubTime":"2025-09-01 18:08","pubTimestamp":1756721296,"startTime":"0","endTime":"0","summary":"健民集团公告，近日，公司从国家药品监督管理局网站获悉，公司研发的呋塞米口服溶液获批上市。呋塞米口服溶液是高效利尿剂，用于心衰、肝硬化、肾病相关的水肿，同时也可用于高血压的治疗，通常有片剂和注射剂两种剂型。口服溶液剂型较原剂型更适合儿童服用，提高用药安全性及依从性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/09/01180852850765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["600976","BK0250","BK0188","BK0209"],"gpt_icon":0},{"id":"2561230047","title":"每周股票复盘：健民集团（600976）股东户数增加3855户，主营收入下降10.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561230047","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561230047?lang=zh_cn&edition=full","pubTime":"2025-08-24 04:05","pubTimestamp":1755979512,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，健民集团报收于41.28元，较上周的41.5元下跌0.53%。本周，健民集团8月19日盘中最高价报43.19元。本周关注点股本股东变化：截至2025年6月30日公司股东户数为1.7万户，较3月31日增加3855.0户业绩披露要点：健民集团2025年中报显示，公司主营收入18.05亿元，同比下降10.2%股本股东变化近日健民集团披露，截至2025年6月30日公司股东户数为1.7万户，较3月31日增加3855.0户，增幅为29.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400000725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600976"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1769333756085,"stockEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":-0.0062},{"period":"3month","weight":-0.1036},{"period":"6month","weight":-0.1353},{"period":"1year","weight":-0.1348},{"period":"ytd","weight":0.0489}],"compareEarnings":[{"period":"1week","weight":0.0083},{"period":"1month","weight":0.0495},{"period":"3month","weight":0.047},{"period":"6month","weight":0.151},{"period":"1year","weight":0.2805},{"period":"ytd","weight":0.0422}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"健民药业集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"14261人(较上一季度减少16.17%)","perCapita":"10749股","listingDate":"2004-04-19","address":"湖北省武汉市汉阳区鹦鹉大道484号","registeredCapital":"15339万元","survey":" 健民药业集团股份有限公司的主营业务是药品的研发、制造、批发与零售业务。公司的主要产品是龙牡壮骨颗粒、便通胶囊、健脾生血颗粒、健脾生血片、小金胶囊、小儿宝泰康颗粒、便通胶囊、中成药、化学药品、生物制剂、保健品、中医诊疗。公司是国家高新技术企业，技术中心通过国家企业技术中心认定。","listedPrice":11.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健民集团(600976)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健民集团(600976)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健民集团,600976,健民集团股票,健民集团股票老虎,健民集团股票老虎国际,健民集团行情,健民集团股票行情,健民集团股价,健民集团股市,健民集团股票价格,健民集团股票交易,健民集团股票购买,健民集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健民集团(600976)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健民集团(600976)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}